Unlocking the Mystery: Unique Brain MRI Pattern Guides Diagnosis of Ultra-Rare Genetic Leukodystrophy
A groundbreaking case study from China details a distinctive 'Beagle sign' on MRI, enhancing clinical recognition of LMNB1-related autosomal dominant leukodystrophy (ADLD).
NeuroBulletin.com — Researchers have identified a striking and characteristic magnetic resonance imaging (MRI) pattern, dubbed the 'Beagle sign,' that could significantly improve the early and accurate diagnosis of an extremely rare inherited neurological condition known as LMNB1-related autosomal dominant leukodystrophy (ADLD). This critical finding emerged from a detailed case report recently published in *Frontiers in Neuroscience* on June 03, 2026, by a team led by Rui-Sheng Duan from The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital in Jinan, China, alongside colleagues Francesca Luisa Conforti and others.
Advancing Recognition of a Cryptic Condition
Adult-onset autosomal dominant leukodystrophy (ADLD) is an exceptionally uncommon genetic disorder affecting the brain's white matter. It stems from specific genetic variations in the *LMNB1* gene. The detailed analysis of a patient's case, outlining both the clinical progression and specific MRI characteristics, aims to provide clinicians with a clearer pathway for identifying this often-misunderstood condition. Its clinical manifestations are diverse, and symptoms typically worsen progressively over time.
The Distinctive 'Beagle Sign' on Brain Imaging
Central to this report is the innovative description of a unique MRI signature observed in ADLD patients. For years, traditional imaging findings in ADLD have included symmetrical white matter lesions, particularly in specific regions like the subcortical white matter, brainstem, and middle cerebellar peduncles, as noted in previous studies by Raininko et al. (1993), Finnsson et al. (2015), Sundblom et al. (2009), and Melberg et al. (2006). However, the current research refines this observation by highlighting how these symmetrical hyperintensities, visible on T2-weighted and FLAIR sequences, particularly within the brainstem corticospinal tract and bilateral middle cerebellar peduncles, strikingly resemble the facial profile of a Beagle dog. This visual analogy, termed the 'Beagle sign,' is designed to facilitate quick visual identification by medical professionals, with the abnormal signal in the brainstem corticospinal tract suggesting the eyes and the hyperintensities in the bilateral peduncles representing the ears.
A Decade-Long Journey to Diagnosis
The patient, a 55-year-old male, presented with a complex medical history spanning a decade. His initial symptoms included incomplete voiding, dysuria, and constipation. Despite undergoing surgical intervention for benign prostatic hyperplasia nine years prior, his urinary issues persisted. A year before his neurological presentation, he began experiencing progressive lower limb weakness, an unsteady gait, numbness in the soles of both feet, a sensation of walking on cotton, and coldness in his lower limbs. His lifestyle history included 30 years of daily alcohol consumption (approximately half a pound of baijiu) and a 30-year smoking habit of 20 cigarettes per day, though he had abstained from alcohol for the past year. He denied any history of sexually transmitted diseases or drug use.
Comprehensive Neurological Evaluation
Upon examination, the patient exhibited slurred speech and an abnormal, wide-based gait with reduced stride length. While the Romberg test was negative, the sharpened Romberg test showed positivity, and tandem walking was unsteady. There was also evidence of impaired recent memory. Neurological reflexes revealed symmetrically hyperactive bilateral patellar tendon reflexes (3+), alongside positive bilateral Hoffmann signs. Muscle strength in all four limbs remained normal. While light touch and pinprick sensations were intact, vibration sense was diminished in the lower limbs but normal in the upper limbs. Coordination tests, such as the finger-to-nose and heel-to-shin tests, showed mild bilateral impairment and unsteadiness, respectively. Routine laboratory results, including vitamin and homocysteine levels, were unremarkable. Further investigations, including lower limb ultrasound, nerve conduction studies, and somatosensory evoked potentials, ruled out other common causes for his symptoms, with only prolonged P38 latency in lower limb somatosensory evoked potentials noted.
Imaging Reveals Characteristic Pathologies
Brain MRI scans provided crucial insights, displaying symmetrical and confluent white matter hyperintensities on T2-weighted images across the frontal, parietal, and occipital lobes. Notably, the periventricular white matter showed lower signal intensity compared to more peripheral white matter. Diffuse T2 hyperintensity was also evident along the entire course of the pyramidal tracts, encompassing the cerebral peduncles, ventral pons, and medulla oblongata's pyramids. The distinctive 'Beagle sign' was clearly visible, formed by white matter hyperintensities in the brainstem and bilateral middle cerebellar peduncles. Perfusion imaging further indicated reduced regional perfusion in the periventricular white matter and pons, suggesting chronic neurodegenerative changes. Magnetic resonance spectroscopy (MRS) corroborated these findings with an elevated lactate peak. These imaging and metabolic alterations are highly indicative of *LMNB1*-related ADLD, which typically presents with frontoparietal white matter lesions, brainstem and middle cerebellar peduncles hyperintensities, and spinal cord atrophy, the latter being confirmed by sagittal and axial T2-weighted cervical spinal MRI revealing diffuse spinal cord atrophy.
Genetic Confirmation and Family Implications
Initial whole-exome sequencing (WES) hinted at a 141.09 kb duplication at 5q23.2 (chr5:126112828–126253919, hg19). This suspicion was definitively confirmed through high-throughput whole-genome sequencing (NGS-CNV-seq) performed on both the patient and his asymptomatic son. This advanced genetic analysis precisely identified an identical 280 kb duplication at the same 5q23.2 locus (chr5:126040001–126320000, hg19) in both individuals. This duplicated region includes the triplosensitive *LMNB1* gene. Classification according to ACMG-CNV guidelines deemed this variant pathogenic, providing a conclusive molecular diagnosis for ADLD and confirming its inherited nature within the family. A three-generation family pedigree (Figure 3) showed the proband (II-3) and his son (III-4) as carriers of the ADLD mutation, while other family members were unaffected and mutation-negative. The son, despite being asymptomatic, carries the genetic duplication, highlighting the importance of genetic counseling.
Ongoing Management and Prognosis
Following the definitive diagnosis of ADLD, the patient and his family received comprehensive counseling regarding the disease's nature and anticipated progression. Symptomatic management was initiated, including multivitamin supplementation, neurotrophic agents, cognitive enhancers, and stool softeners, alongside dietary recommendations. Since discharge, the patient has maintained a stable condition through regular follow-up visits at the outpatient clinic, with his clinical milestones and progression detailed in a comprehensive timeline (Figure 2).
Leukodystrophies, as a broader category, encompass a group of rare, progressive inherited disorders characterized by genetic factors that impair myelination and disrupt normal development, as described by Van Der Knaap et al. (2019). While many leukodystrophies manifest in infancy, ADLD typically presents in adulthood, underscoring the diagnostic challenges and the significance of this new imaging marker.
Latest Updates on this Story
This breaking news report sheds light on a significant diagnostic breakthrough for a rare neurological disorder, offering new hope for earlier intervention. Researchers are currently exploring the broader applicability of the 'Beagle sign' in diverse patient populations, with live coverage of ongoing studies expected to emerge. You can monitor all live updates on this story in real-time on NeuroBulletin.com.
Related Topics
🔹 Autosomal Dominant Leukodystrophy 🔹 LMNB1 Gene Duplication 🔹 Brain MRI Diagnostics 🔹 Neurological Imaging Markers 🔹 Rare Genetic Disorders 🔹 Cerebellar Ataxia 🔹 Neurodegenerative Diseases 🔹 Case Report
About NeuroBulletin News
NeuroBulletin.com is the leading independent resource for cutting-edge neuroscience research and brain health news. Our dedicated team of expert editors provides in-depth, objective coverage of complex neurological conditions, groundbreaking discoveries, and clinical advancements. We aim to keep our readers informed about the latest developments that impact brain health worldwide.
Frequently Asked Questions
What is LMNB1-related autosomal dominant leukodystrophy (ADLD)?
ADLD is an ultra-rare, inherited white matter disorder that affects the brain and spinal cord, typically manifesting in adulthood. It is caused by genetic variants, specifically duplications, in the *LMNB1* gene, leading to issues with myelin, the protective sheath around nerve fibers.
What is the 'Beagle sign' in the context of ADLD diagnosis?
The 'Beagle sign' is a characteristic pattern observed on brain MRI scans (T2-weighted/FLAIR images) of ADLD patients. It describes symmetrical hyperintensities in the brainstem corticospinal tract and bilateral middle cerebellar peduncles, which visually resemble the facial profile of a Beagle dog, aiding in clinical recognition.
How is ADLD diagnosed?
Diagnosis of ADLD typically involves a combination of clinical presentation (symptoms like autonomic dysfunction, motor impairment, cerebellar ataxia), characteristic MRI findings (such as the 'Beagle sign' and white matter lesions), and definitive genetic testing that identifies pathogenic variants or duplications in the *LMNB1* gene.
Is LMNB1-related ADLD an inherited condition?
Yes, ADLD is an autosomal dominant inherited disorder, meaning that only one copy of the altered *LMNB1* gene in each cell is sufficient to cause the condition. It can be passed down from an affected parent to their children with a 50% chance for each child to inherit the mutation.